Table 7.

Acute Inpatient Treatment in Individuals with LCHAD/TFP Deficiency

Manifestation/
Concern
TreatmentConsiderations/Other
Hypoglycemia
  • IV fluid w/high dextrose content (≥10%) to maintain blood glucose >100 mg/dL. 1
  • Starting fluid at 1.5x maintenance usually achieves this goal.
  • Glucose infusion rate of 8-12 mg/kg/min is usually needed for young children.
  • High-dose glucose is needed to avoid catabolism.
  • If there is hyperglycemia, start insulin infusion rather than reducing glucose infusion rate.
Metabolic
acidosis
  • For severe metabolic acidosis (pH <7.10), initiate bicarbonate therapy.
  • A common formula for bicarbonate dose: bicarbonate (mEq) = 0.5 x weight (kg) x [desired bicarbonate − measured bicarbonate]
  • Give 1/2 of calculated dose as slow bolus & remaining 1/2 over 24 hrs.
  • Metabolic acidosis usually improves w/generous fluid & calorie support. 2
  • Bicarbonate therapy is needed for severe metabolic acidosis. 3
Hyperammonemia
  • Hyperammonemia improves w/reversal of catabolism.
  • High-dose glucose infusion w/insulin infusion is helpful in achieving this goal.
  • If severe hyperammonemia & altered mental status persists after above measures, consider extracorporeal toxin removal procedures such as hemodialysis & hemofiltration.
Although IV sodium benzoate w/sodium phenylacetate have been used in such circumstances, their utility is doubtful.
Rhabdomyolysis
  • Start IV fluid containing 10% dextrose & electrolytes as needed at 2x maintenance (in children) to provide adequate hydration & calories & ensure urine output of >3 mL/kg/hr to prevent acute renal failure. 4
  • For adults, start IV fluid at 400 mL/hour; tailor to maintain urine output of ~200 mL/hr. 5
  • If there is acute renal failure at presentation, consult nephrologist for hemodialysis.
  • Avoid treatment of rhabdomyolysis by glucose-free hypotonic IV fluid such as 0.45 normal saline, as it will promote catabolism & worsen rhabdomyolysis.
  • If hyperglycemia develops due to high dextrose infusion, start insulin infusion.
Cardiac failure Manage cardiac failure due to cardiomyopathy in collaboration w/cardiologist.Consider triheptanoin for those persons not taking it, as it was reported to be useful in mgmt of acute cardiomyopathy. 6

IV = intravenous; LCHAD = long-chain hydroxyacyl-CoA dehydrogenase; TFP = trifunctional protein

1.

Monitor blood glucose levels every 1-2 hours initially.

2.

Intralipid administration is contraindicated; supplemental calories should be provided in the form of carbohydrates.

3.

Note that bicarbonate therapy alone is not sufficient to correct the metabolic acidosis. Correction of metabolic acidosis relies on reversing the catabolic state by providing calorie support from glucose.

4.
5.
6.

Triheptanoin was found to be useful in management of cardiomyopathy in both chronic and acute settings [Vockley et al 2016].

From: Long-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency / Trifunctional Protein Deficiency

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.